Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study.
Savoldi A, Morra M, Castelli A, Mirandola M, Berkell M, Smet M, Konnova A, Rossi E, Cataudella S, De Nardo P, Gentilotti E, Gupta A, Fasan D, Gibbin E, Cioli Puviani F, Hasenauer J, Gusinow R, Tami A, Kumar-Singh S, Malhotra-Kumar S, mAb Orchestra Working Group, Tacconelli E.
Savoldi A, et al. Among authors: tami a.
Biomedicines. 2022 Aug 24;10(9):2063. doi: 10.3390/biomedicines10092063.
Biomedicines. 2022.
PMID: 36140162
Free PMC article.